Orbital Sciences Announces Successful Satellite Launch and 3 Stocks Enjoying 52-Week Highs
Neurocrine Biosciences (NASDAQ:NBIX): Closing price $10.84
The firm estimates its fiscal year 2013 revenue at $3 million, which is comprised solely of the amortization of up-front license fees. The revenue consensus is $25.63 million. Also, the net cash burn from operations during the same period is projected at between $50 million and $55 million, along with a fiscal-year-end $130 million in cash, investments and receivables. Shares closed up.5.96 percent on the day at $10.84, and have been traded in a 52-week range of $6.25 to $10.76.
Orbital Sciences (NYSE:ORB): Closing price $15.37
Orbital Sciences reported that its company-built Azerspace/Africasat-1a commercial communications satellite was successfully launched into orbit on February 7th, aboard an Ariane 5 rocket from the Guiana Space Centre in Kourou, Guyane. Shares closed up 1.45 percent on the day at $15.37, having been traded in a 52-week range of $10.59 to $15.18.
Johnson & Johnson (NYSE:JNJ): Closing price $75.48
A surgeon in Montana has testified that he eased the use of Johnson & Johnson’s ASR all-metal hip device eight monthsprior to the recall because a sales representative warned about problems with the implant, says Bloomberg. Peter Wendt affirmed that he implanted 76 ASRs, including one in Loren Kransky, 65, of Montana. Kransky’s lawsuit is the first of 10,000 to go to court in regards to claims that J&J’s DePuy unit defectively designed the 93,000 hips recalled in August 2010, and did not warn of the risks. For its part the firm denies that it defectively designed the device or that it contributed to the health problems of Kransky. Shares closed up 0.56 percent on the day at $75.48, and have been traded in a 52-week range of $61.71 to $75.39.
Corporate Office Properties Trust (NYSE:OFC): Closing price $26.69
The company posted its fourth quarter revenue at $137.5 million, with a consensus of $92.31 million, and fourth quarter funds from operations of 51 cents. Shares closed up 1.41 percent on the day at $26.69, having been traded in a 52-week range of $21.13 to $27.25.
Don’t Miss: Apple Now Stands Alone in E-Book Case.